Nirmal Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Heart failure1 trial
• High blood pressure1 trial
• Lupus (SLE)1 trial
• Type 2 diabetes1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial
• Suspended1 trial
• Terminated1 trial

Lead sponsor

• Boehringer Ingelheim2 trials
• Eli Lilly and Company2 trials
• Kezar Life Sciences, Inc.1 trial

Running trials

• Recruiting

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

  NCT03519945· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting

Closed trials

• Terminated

  A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

  NCT05781750· Phase 2· Kezar Life Sciences, Inc.· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source